Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a dedicated Locations section with Georgia listed as a site. Also removed the HHS Vulnerability Disclosure and Georgia Locations entries, and updated the revision to v3.3.3.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of Revision: v3.2.0. This reflects a site update/versioning detail.SummaryDifference0.1%

- Check66 days agoChange DetectedThe notice about government funding operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedThe changes appear limited to administrative updates (e.g., last update date) with no modifications to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check108 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.